AAV vector mediated gone therapy of Fabry knockout mice.

被引:0
|
作者
Shimada, T
Zenri, K
Ogawa, K
Takahashi, H
Hirai, Y
Seino, Y
Fukuda, Y
机构
[1] Nippon Med Sch, Dept Biochem, Tokyo 113, Japan
[2] Nippon Med Sch, Dept Internal Med, Tokyo 113, Japan
[3] Nippon Med Sch, Dept Pathol, Tokyo 113, Japan
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
2686
引用
收藏
页码:626 / 626
页数:1
相关论文
共 50 条
  • [31] Assessment of Toxicity and Biodistribution of an AAV2/8 Vector-Mediated Immunomodulatory Gene Therapy in Mice With Pompe Disease
    Han, Sang-oh
    Wang, Gensheng
    Young, Sarah
    Bali, Deeksha
    Benson, Janet
    Koeberl, Dwight
    MOLECULAR THERAPY, 2014, 22 : S19 - S19
  • [32] Intravenous administration of lentiviral vector, or adeno-associated virus (AAV) vector, produces metabolic and phenotypic correction of Hurler syndrome in mice.
    Whitley, CB
    Pan, D
    Hartung, SD
    Frandsen, JL
    Gunther, R
    Low, WC
    Walkley, SU
    McIvor, RS
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 622 - 622
  • [33] Adeno-Associated Virus (AAV)-Mediated Gene Therapy in Nphs1 Knockout Mice: A Strategy for Treating Congenital Nephrotic Syndrome
    Saida, Ken
    Yu, Seyoung
    Braun, Alina
    Franken, Gijs A. C.
    Lomjansook, Kraisoon
    Lemberg, Katharina
    Kolvenbach, Caroline Maria
    Mansour, Bshara
    Yousef, Kirollos
    Riedhammer, Korbinian M.
    Mertens, Nils David
    Elmubarak, Izzeldin
    Schneider, Ronen
    Shril, Shirlee
    Buerger, Florian
    Hildebrandt, Friedhelm
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [34] Elevated levels of globotriaosylceramide in salivary glands of Fabry mice.
    Kulkarni, AB
    Han, I
    Limaye, A
    Ambudkar, I
    Ward, J
    Sreenath, T
    Brady, RO
    Qasba, P
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A153 - A153
  • [35] Systematic gene therapy derived from an investigative study of AAV2/8 vector gene therapy for Fabry disease
    Deng, Mulan
    Zhou, Hongyu
    He, Shaomei
    Qiu, Haoheng
    Wang, Yanping
    Zhao, April Yuanyi
    Mu, Yunping
    Li, Fanghong
    Zhao, Allan Zijian
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [36] Systematic gene therapy derived from an investigative study of AAV2/8 vector gene therapy for Fabry disease
    Mulan Deng
    Hongyu Zhou
    Shaomei He
    Haoheng Qiu
    Yanping Wang
    April Yuanyi Zhao
    Yunping Mu
    Fanghong Li
    Allan Zijian Zhao
    Orphanet Journal of Rare Diseases, 18
  • [37] Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice
    Rodrigues, L. G.
    Ferraz, M. J.
    Rodrigues, D.
    Pais-Vieira, M.
    Lima, D.
    Brady, R. O.
    Sousa, M. M.
    Sa-Miranda, M. C.
    NEUROBIOLOGY OF DISEASE, 2009, 33 (01) : 48 - 56
  • [38] Immune Response to AAV Vector Capsid and Assessment of Eligibility for AAV-Mediated Gene Therapy for Duchenne Muscular Dystrophy
    Saha, Rima
    Meyers, Craig
    Coleman, Kirsten
    Trivedi, Prasad
    Bhake, Radhika
    Byrne, Barry J.
    Corti, Manuela
    MOLECULAR THERAPY, 2023, 31 (04) : 546 - 547
  • [39] Primary cilia in polycystin-2 knockout mice.
    Horst, J
    Pennekamp, P
    Lewandowski, G
    Rasch, C
    Reichelt, R
    Dworniczak, B
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 324 - 324
  • [40] Suppression of UV carinogenesis by DFMO in XPA knockout mice.
    Rebel, HG
    van Steeg, H
    Terleth, C
    de Gruijl, FR
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1999, 69 : 30S - 31S